Target Engagement Analysis and Link to Pharmacodynamic Endpoint for a Novel Class of CNS-penetrant and Efficacious p38α MAPK Inhibitors

Adam D. Bachstetter(University of Kentucky), Linda J. Van Eldik(University of Kentucky)
Journal of Neuroimmune Pharmacology
April 30, 2014
Cited by 13


Related Papers